We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A study coordinator allegedly forged the signatures of parents or legally authorized representatives for three pediatric subjects on informed consent forms for two Phase IIIb clinical trials of Schering-Plough’s anesthesia drug Zemuron, according to an FDA warning letter to the clinical investigator, Charles Cote.